Search results for " Project"

showing 10 items of 1296 documents

Mobile microscopy as a screening tool for oral cancer in India: A pilot study

2017

Oral cancer is the most common type of cancer among men in India and other countries in South Asia. Late diagnosis contributes significantly to this mortality, highlighting the need for effective and specific point-of-care diagnostic tools. The same regions with high prevalence of oral cancer have seen extensive growth in mobile phone infrastructure, which enables widespread access to telemedicine services. In this work, we describe the evaluation of an automated tablet-based mobile microscope as an adjunct for telemedicine-based oral cancer screening in India. Brush biopsy, a minimally invasive sampling technique was combined with a simplified staining protocol and a tablet-based mobile mi…

MaleBiopsylcsh:MedicinePilot ProjectsPathology and Laboratory MedicineCytopathologyAutomationUser-Computer Interface0302 clinical medicineImage Processing Computer-AssistedMedicine and Health SciencesMedicineMedical diagnosislcsh:ScienceEarly Detection of CancerMouth neoplasmMicroscopyMultidisciplinaryMiddle AgedOncology030220 oncology & carcinogenesisFemaleMouth NeoplasmsAnatomyTelepathologyResearch ArticleAdultTelemedicinemedicine.medical_specialtyHistologyConcordanceIndiaSurgical and Invasive Medical ProceduresRemote evaluationSensitivity and SpecificityCarcinomasYoung Adult03 medical and health sciencesSigns and SymptomsDiagnostic MedicineCancer Detection and DiagnosisHumansMedical physicsAgedDemographybusiness.industrylcsh:RBiology and Life SciencesCancers and NeoplasmsCell Biology030206 dentistryGold standard (test)Anatomical PathologyMobile phoneLesionslcsh:QCytologybusinessCell PhonePLOS ONE
researchProduct

Efficacy of quetiapine XR vs. placebo as concomitant treatment to mood stabilizers in the control of subthreshold symptoms of bipolar disorder: Resul…

2017

Patients with bipolar disorder (BD) do not always achieve full remission between episodes. Subthreshold symptoms (depressive, manic or mixed) represent a major cause of relapse and disability in these patients. Immediate release (IR) and extended release (XR) formulations of quetiapine are both indicated for short and long-term treatment of BD. The aim of this study was to evaluate the efficacy of quetiapine XR vs placebo in subthreshold symptomatology when added to previous mood stabilizer treatment. A pilot phase IIIB, multicentre, prospective, placebo controlled, randomized, double blinded study of 12 weeks follow-up was performed (NCT01197846). Patients were randomized to quetiapine XR …

MaleBipolar Disorder*Bipolar disorderPilot Projectslaw.invention0302 clinical medicineRandomized controlled triallawAntimanic AgentsAmbulatory CarePharmacology (medical)*QuetiapineMood stabilizerMiddle AgedSubthreshold symptomsPsychiatry and Mental healthTreatment OutcomeNeurologyDrug Therapy CombinationFemalemedicine.symptomPsychologySomnolencemedicine.drugAdultmedicine.medical_specialtyAdolescentmedicine.drug_classBipolar disorderPlacebo03 medical and health sciencesQuetiapine FumarateYoung AdultDouble-Blind MethodInternal medicinemedicineHumans*Subthreshold symptomsBipolar disorderPsychiatryAdverse effectBiological PsychiatryAgedPharmacologyPsychiatric Status Rating ScalesQuetiapineBody Weightmedicine.disease030227 psychiatryMoodDelayed-Action PreparationsQuetiapineNeurology (clinical)030217 neurology & neurosurgeryFollow-Up Studies
researchProduct

Recanalization Therapies in Acute Ischemic Stroke Patients Impact of Prior Treatment With Novel Oral Anticoagulants on Bleeding Complications and Out…

2015

Background— We explored the safety of intravenous thrombolysis (IVT) or intra-arterial treatment (IAT) in patients with ischemic stroke on non-vitamin K antagonist oral anticoagulants (NOACs, last intake <48 hours) in comparison with patients (1) taking vitamin K antagonists (VKAs) or (2) without previous anticoagulation (no-OAC). Methods and Results— This is a multicenter cohort pilot study. Primary outcome measures were (1) occurrence of intracranial hemorrhage (ICH) in 3 categories: any ICH (ICH any ), symptomatic ICH according to the criteria of the European Cooperative Acute Stroke Study II (ECASS-II) (sICH ECASS-II ) and the National Institute of Neurological Disorders and Stroke …

MaleBrain Ischemia/blood/drug therapyVitamin Kmedicine.medical_treatmentendovascular proceduresAnticoagulants/administration & dosage/adverse effects/classification/therapeutic useAdministration OralPilot ProjectsTissue plasminogen activatorBrain IschemiaCohort Studies2737 Physiology (medical)Atrial Fibrillation80 and overThrombolytic TherapyVitamin K/antagonists & inhibitorsStrokethrombolytic therapyAged 80 and overIncidenceAtrial fibrillationThrombolysisMiddle Aged3. Good healthvitamin K antagonistsTreatment OutcomeAdministrationAcute DiseaseCohortCerebral Hemorrhage/chemically induced/epidemiologyFemaleCardiology and Cardiovascular MedicineAtrial Fibrillation/complicationsmedicine.drugOralmedicine.medical_specialtyanticoagulantsnon-vitamin K antagonist oral anticoagulantsFactor Xa Inhibitors/administration & dosage/adverse effects/therapeutic useintracranial hemorrhagesintra-arterial treatment610 Medicine & healthAntithrombins2705 Cardiology and Cardiovascular MedicineDabigatranFibrinolytic AgentsPhysiology (medical)Internal medicinemedicineischemic strokeHumansAgedCerebral HemorrhageIntracerebral hemorrhageFibrinolytic Agents/therapeutic usebusiness.industryAntithrombins/administration & dosage/adverse effects/therapeutic usemedicine.diseaseddc:616.810040 Clinic for Neurologyanticoagulants; endovascular procedures; intra-arterial treatment; intracranial hemorrhages; ischemic stroke; non-vitamin K antagonist oral anticoagulants; thrombolytic therapy; vitamin K antagonistsPropensity score matchingbusinessFactor Xa InhibitorsCirculation
researchProduct

ERGO: A pilot study of ketogenic diet in recurrent glioblastoma

2014

Limiting dietary carbohydrates inhibits glioma growth in preclinical models. Therefore, the ERGO trial (NCT00575146) examined feasibility of a ketogenic diet in 20 patients with recurrent glioblastoma. Patients were put on a low-carbohydrate, ketogenic diet containing plant oils. Feasibility was the primary endpoint, secondary endpoints included the percentage of patients reaching urinary ketosis, progression-free survival (PFS) and overall survival. The effects of a ketogenic diet alone or in combination with bevacizumab was also explored in an orthotopic U87MG glioblastoma model in nude mice. Three patients (15%) discontinued the diet for poor tolerability. No serious adverse events attri…

MaleCancer ResearchStatement (logic)medicine.medical_treatmentSalvage treatmentPilot ProjectsBioinformaticsGastroenterologyMicegliomaClinical endpoint1306 Cancer ResearchglucoseArticlesMiddle AgedCombined Modality TherapyBevacizumabTreatment OutcomeTolerabilityOncologyketogenic dietFemale2730 OncologyDiet Ketogenicmedicine.drugAdultmedicine.medical_specialtyBevacizumabMice NudeAntineoplastic Agents610 Medicine & healthMistakeRecurrent GliomaBiologyAntibodies Monoclonal HumanizedInternal medicineGliomamedicineAnimalsHumansddc:610Adverse effectAgedbusiness.industryRecurrent glioblastomaGeneral surgeryKetosisNeoplasms Experimentalmedicine.diseaseSurvival Analysis10040 Clinic for NeurologySurgeryQuality of LifeNeoplasm Recurrence LocalKetosisGlioblastomabusinessmetabolismfeasibilityKetogenic dietInternational Journal of Oncology
researchProduct

A Pilot Study on Prostate Cancer Risk and Pro-Inflammatory Genotypes: Pathophysiology and Therapeutic Implications

2010

Host genetic factors are crucial risk determinants for many human cancers. In this framework, an interesting model is represented by prostate cancer (PC), which is featured by a complex pathophysiology with a strong genetic component. Multiple genes seem to influence PC risk and several single nucleotide polymorphisms (SNPs) of candidate genes modifying PC susceptibility have been identified. It is noteworthy the potential association of common SNPs in pro-inflammatory genes with PC risk, since chronic inflammation is assumed to play a key role in prostate carcinogenesis. With the aim to identify candidate genes as an experimental basis to develop new strategies for both prevention and trea…

MaleCandidate geneGenotypePilot ProjectsSingle-nucleotide polymorphismBioinformaticsPolymorphism Single NucleotideProstate cancerRisk FactorsDrug DiscoveryGenotypemedicineHumansSNPSettore MED/05 - Patologia ClinicaGeneAgedAged 80 and overInflammationPharmacologySettore MED/04 - Patologia Generalebusiness.industryProstatic NeoplasmsCancerMiddle AgedProstate cancer (PC) inflammation genetics TLR4 TLR2 PTGS2 5-LO SNP.medicine.diseaseImmunologyTLR4Inflammation Mediatorsbusiness
researchProduct

The bite force and craniofacial morphology in patients with acromegaly: A pilot study

2013

Objectives: Acromegaly is a metabolic disorder caused by increased growth hormone secretion. As a consequence of acromegaly some typical craniofacial morphology changes appear. This pilot study was conducted to compare the bite force and the characteristic size and shape of the craniofacial components of acromegalic patients with the healthy Turkish individuals. In additon, the correlations between bite force and craniofacial morphology of patients with acromegaly and control individuals were evaluated. Study Design: The maximum bite force of the participants was recorded with strain-gage transducer. Lateral xray scans were made under standard conditions, in centric occlusion. On cephalogra…

MaleCephalometryCraniofacial abnormalityDentistryPilot ProjectsOdontologíaBite ForceCraniofacial AbnormalitiesAcromegalyHumansMedicineGonial angleCraniofacialGeneral DentistryOral Medicine and Pathologybusiness.industryResearchMandibleCraniometrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludBite force quotientSella turcicamedicine.anatomical_structureOtorhinolaryngologyAcromegalyUNESCO::CIENCIAS MÉDICASFemaleSurgerybusiness
researchProduct

Prevention and contrast of child abuse and neglect in the practice of European paediatricians: a multi-national pilot study

2021

AbstractBackgroundChild abuse and neglect, or maltreatment, is a serious public health problem, which may cause long-term effects on children’s health and wellbeing and expose them to further adulthood vulnerabilities. Studies on child maltreatment performed in Europe are scarce, and the number of participants enrolled relatively small. The aim of this multi-national European pilot study, was to evaluate the level of understanding and perception of the concepts of child abuse and neglect by European paediatricians working in different medical settings, and the attitude toward these forms of maltreatment in their practice.MethodsThe study was performed by a cross-sectional, descriptive, onli…

MaleChild abusemedicine.medical_specialtyViolence.media_common.quotation_subjecteducationPilot ProjectsViolencePediatricsAbuseRJ1-570Neglect03 medical and health sciences0302 clinical medicineSurveys and Questionnaires030225 pediatricsPerceptionMaltreatmentmedicineHumansChild AbusePediatricians030212 general & internal medicineChildPhysician's RoleCurriculumNeglectmedia_commonMultiple choicebusiness.industryResearchPublic healthChild HealthGeneral MedicineAbuse ; Child ; Maltreatment ; Neglect ; ViolenceEXPOSEEuropeCross-Sectional StudiesPrivate practiceFamily medicineFemalebusinessItalian Journal of Pediatrics
researchProduct

Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: An 8-month prospective pi…

2015

Objective: To explore the effects of the glucagon-like peptide-1 receptor analogue liraglutide on subclinical atherosclerosis in diabetic subjects with non-alcoholic fatty liver disease (NAFLD).Research design and methods: In this 8-month prospective study, 29 subjects with type 2 diabetes (T2DM) and NAFLD (16 men and 13 women, mean age: 61 ± 10 years) were matched for age and gender with 29 subjects with T2DM without NAFLD (16 men and 13 women, mean age: 61 ± 8 years). Liraglutide 0.6 mg/day for 2 weeks, followed by 1.2 mg/day, was given in addition to metformin.Main outcome measures: Anthropometric variables, glucometabolic parameters and carotid intima-media thickness (IMT) using B-mode …

MaleClinical BiochemistryPilot ProjectsType 2 diabetesCarotid Intima-Media ThicknessGastroenterologychemistry.chemical_compoundRisk FactorsDrug DiscoveryProspective StudiesProspective cohort studyliraglutideMedicine (all)Fatty liverLipidMiddle AgedLipidsHemoglobin AAtherosclerosiFemalemedicine.drugHumanmedicine.medical_specialtycarotid intima-media thickneInternal medicineDiabetes mellitusmedicineHumansHypoglycemic AgentsPilot ProjectAgedGlycated HemoglobinHemoglobin A GlycosylatedPharmacologytype 2 diabeteHypoglycemic AgentLiraglutidebusiness.industryRisk FactorDrug Discovery3003 Pharmaceutical Sciencenutritional and metabolic diseasesnon-alcoholic fatty liver diseaseAtherosclerosismedicine.diseaseProspective StudieEndocrinologychemistryIntima-media thicknessDiabetes Mellitus Type 2Glycated hemoglobinbusiness
researchProduct

A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer.

2015

Background Artesunate is an antimalarial agent with broad anti-cancer activity in in vitro and animal experiments and case reports. Artesunate has not been studied in rigorous clinical trials for anticancer effects. Aim To determine the anticancer effect and tolerability of oral artesunate in colorectal cancer (CRC). Methods This was a single centre, randomised, double-blind, placebo-controlled trial. Patients planned for curative resection of biopsy confirmed single primary site CRC were randomised (n = 23) by computer-generated code supplied in opaque envelopes to receive preoperatively either 14 daily doses of oral artesunate (200 mg; n = 12) or placebo (n = 11). The primary outcome meas…

MaleColorectal cancerResistancelcsh:MedicineAdministration OralArtesunatePilot ProjectsPharmacologyGastroenterologyPlacebosNeutropaeniachemistry.chemical_compoundCancerlcsh:R5-920medicine.diagnostic_testGeneral MedicineImmunohistochemistryArtemisininsDihydroartemisininTreatment OutcomeTolerabilityOriginal ArticleFemalelcsh:Medicine (General)Colorectal NeoplasmsKi67medicine.medical_specialtyRandomizationPlaceboGeneral Biochemistry Genetics and Molecular BiologyDouble-Blind MethodMedian follow-upInternal medicineBiopsymedicineBiomarkers TumorHumansAgedDemographyStaining and Labelingbusiness.industrylcsh:Rmedicine.diseaseColorectal cancerSurvival AnalysisCarcinoembryonic AntigenMalariaClinical trialKi-67 AntigenchemistryArtesunateCommentarybusinessEBioMedicine
researchProduct

Intrinsic challenges in ancient microbiome reconstruction using 16S rRNA gene amplification

2015

AbstractTo date, characterization of ancient oral (dental calculus) and gut (coprolite) microbiota has been primarily accomplished through a metataxonomic approach involving targeted amplification of one or more variable regions in the 16S rRNA gene. Specifically, the V3 region (E. coli 341–534) of this gene has been suggested as an excellent candidate for ancient DNA amplification and microbial community reconstruction. However, in practice this metataxonomic approach often produces highly skewed taxonomic frequency data. In this study, we use non-targeted (shotgun metagenomics) sequencing methods to better understand skewed microbial profiles observed in four ancient dental calculus speci…

MaleComputational biologyBiologyMethanobrevibacterPrehistòriaArticleRNA Ribosomal 16SHumansDental CalculusMicrobiomePhylogenyGeneticsMultidisciplinaryBacteriaShotgun sequencingMicrobiotaGastrointestinal MicrobiomeGene AmplificationHigh-Throughput Nucleotide SequencingAmpliconHypervariable regionGastrointestinal MicrobiomeAncient DNAArchaeologyMetagenomicsEarth Microbiome ProjectMetagenomeNucleic Acid ConformationFemaleMetagenomics
researchProduct